University of California San Francisco
Helen Diller Family Comprehensive Cancer Center
Robert Ohgami, MD, PhD

Robert Ohgami, MD, PhD

Associate Professor of Clinical Pathology, UCSF

Cancer Center Program Memberships

Hematopoietic Malignancies

Education

  • Princeton University, A.B., 05/00, Molecular Biology
  • Harvard University, Ph.D., 06/06, Cell and Developmental Biology
  • Harvard Medical School, M.D. (cum laude), 06/08, Medicine
  • Massachusetts Institute of Technology, Program Graduate (HST), 06/08, Health Sciences and Technology
  • Stanford University Medical Center, Residency, 07/08, Anatomic Pathology
  • Stanford University Medical Center, Fellowship, 07/10, Hematopathology
  • Stanford University, Postdoctoral Fellowship, 07/11, Hematopathology/Immunology

Professional Experience

  • 2010-2012
    Associate program director, Stanford Society of Physician Scholars
  • 2012-2015
    Clinical Instructor in Pathology, Stanford University
  • 2015-2018
    Assistant Professor of Pathology, Stanford University
  • 2018-2019
    Associate Professor of Pathology, Stanford University
  • 2017-2019
    Associate program director for Anatomic Pathology, Stanford University
  • 2018-2019
    Director of the Molecular Pathology Core
  • 2019-present
    Associate Professor of Clinical Pathology, UCSF
  • 2019-present
    Chief of Hematopathology, UCSF

Honors & Awards

  • 1997
    Pyka Prize for Excellence in Physics, Princeton University
  • 1998
    President's Award for Academic Excellence, Princeton University
  • 2000
    summa cum laude, Princeton University
  • 2000
    George Khoury '65 Senior Prize for Academic Excellence, Princeton University
  • 2000
    Phi Beta Kappa, Princeton University
  • 2000
    Medical Scientist Training Program (MSTP) Scholarship, Harvard
  • 2005
    American Society of Hematology Travel Award
  • 2005
    International BioIron Society Travel Award
  • 2006
    American Society of Hematology Trainee Research Award
  • 2008
    National Scholars Honor Society Merit Award
  • 2008
    cum laude, Harvard Medical School
  • 2008
    American Society of Hematology Trainee Research Award
  • 2010
    Honorary Scholar, Stanford Society of Physician Scholars
  • 2012
    College of American Pathologists Scholars Research Fellowship
  • 2014
    CP Junior Faculty Teaching Award, Stanford Department of Pathology
  • 2016
    Berard-Dorfman Founders Award, Society for Hematopathology
  • 2016
    AP Junior Faculty Teaching Award, Stanford Department of Pathology
  • 2018
    Archer Challenge Grant, Honorable Mention
  • 2018
    Million Dollar Bike Ride Pilot Grant, University of Pennsylvania

Selected Publications

  1. Kumar J, Butzmann A, Wu S, Easly S, Zehnder JL, Warnke RA, Bangs CD, Jangam D, Cherry A, Lau J, Nybakken G, Ohgami RS. Indolent In Situ B-Cell Neoplasms With MYC Rearrangements Show Somatic Mutations in MYC and TNFRSF14 by Next-generation Sequencing. Am J Surg Pathol. 2019 Jul 25.
    View on PubMed
  2. Sridhar K, Singh A, Butzmann A, Jangam D, Ohgami RS. Molecular genetic testing methodologies in hematopoietic diseases: current and future methods. Int J Lab Hematol. 2019 May; 41 Suppl 1:102-116.
    View on PubMed
  3. Thauland TJ, Pellerin L, Ohgami RS, Bacchetta R, Butte MJ. Case Study: Mechanism for Increased Follicular Helper T Cell Development in Activated PI3K Delta Syndrome. Front Immunol. 2019; 10:753.
    View on PubMed
  4. Lezama L, Ohgami RS. Expounding on the essence of epigenetic and genetic abnormalities in blastic plasmacytoid dendritic cell neoplasms. Haematologica. 2019 Apr; 104(4):642-643.
    View on PubMed
  5. Li P, Shahmarvand N, Lynch D, Gotlib JR, Merker JD, Zehnder JL, George TI, Ohgami RS. Revisiting diagnostic criteria for myelodysplastic/myeloproliferative neoplasms with ring sideroblasts and thrombocytosis: Borderline cases without anemia exist. Int J Lab Hematol. 2019 Jun; 41(3):345-352.
    View on PubMed
  6. Singh A, Ohgami RS. Super-Resolution Digital Pathology Image Processing of Bone Marrow Aspirate and Cytology Smears and Tissue Sections. J Pathol Inform. 2018; 9:48.
    View on PubMed
  7. Farris M, Hughes RT, Lamar Z, Soike MH, Menke JR, Ohgami RS, Winkfield K. Histiocytic Sarcoma Associated With Follicular Lymphoma: Evidence for Dramatic Response With Rituximab and Bendamustine Alone and a Review of the Literature. Clin Lymphoma Myeloma Leuk. 2019 Jan; 19(1):e1-e8.
    View on PubMed
  8. Mi X, Griffin G, Lee W, Patel S, Ohgami R, Ok CY, Wang S, Geyer JT, Xiao W, Roshal M, Garcia JS, Silverman LB, Sallan SE, Aster JC, Harris MH, Weinberg OK. Genomic and clinical characterization of B/T mixed phenotype acute leukemia reveals recurrent features and T-ALL like mutations. Am J Hematol. 2018 11; 93(11):1358-1367.
    View on PubMed
  9. Ustun C, Morgan E, Moodie EEM, Pullarkat S, Yeung C, Broesby-Olsen S, Ohgami R, Kim Y, Sperr W, Vestergaard H, Chen D, Kluin PM, Dolan M, Mrózek K, Czuchlewski D, Horny HP, George TI, Kristensen TK, Ku NK, Yi CA, Møller MB, Marcucci G, Baughn L, Schiefer AI, Hilberink JR, Pullarkat V, Shanley R, Kohlschmidt J, Coulombe J, Salhotra A, Soma L, Cho C, Linden MA, Akin C, Gotlib J, Hoermann G, Hornick J, Nakamura R, Deeg J, Bloomfield CD, Weisdorf D, Litzow MR, Valent P, Huls G, Perales MA, Borthakur G. Core-binding factor acute myeloid leukemia with t(8;21): Risk factors and a novel scoring system (I-CBFit). Cancer Med. 2018 09; 7(9):4447-4455.
    View on PubMed
  10. Sumarriva Lezama L, Chisholm KM, Carneal E, Nagy A, Cascio MJ, Yan J, Chang CC, Cherry A, George TI, Ohgami RS. An analysis of blastic plasmacytoid dendritic cell neoplasm with translocations involving the MYC locus identifies t(6;8)(p21;q24) as a recurrent cytogenetic abnormality. Histopathology. 2018 Nov; 73(5):767-776.
    View on PubMed
  11. Lau H, Nagy A, Atwater SK, Cascio MJ, Ohgami RS. An integrated flow cytometry analysis of 286 mature B cell neoplasms identifies CD13 as a useful marker for diagnostic subtyping. Int J Lab Hematol. 2018 Dec; 40(6):715-720.
    View on PubMed
  12. Gars E, Purington N, Scott G, Chisholm K, Gratzinger D, Martin BA, Ohgami RS. Bone marrow histomorphological criteria can accurately diagnose hemophagocytic lymphohistiocytosis. Haematologica. 2018 Oct; 103(10):1635-1641.
    View on PubMed
  13. Nagy A, Bhaduri A, Shahmarvand N, Shahryari J, Zehnder JL, Warnke RA, Mughal T, Ali S, Ohgami RS. Next-generation sequencing of idiopathic multicentric and unicentric Castleman disease and follicular dendritic cell sarcomas. Blood Adv. 2018 03 13; 2(5):481-491.
    View on PubMed
  14. Shahmarvand N, Nagy A, Shahryari J, Ohgami RS. Mutations in the signal transducer and activator of transcription family of genes in cancer. Cancer Sci. 2018 Apr; 109(4):926-933.
    View on PubMed
  15. Ohgami RS, Rosenwald A, Bagg A. Next-Generation Sequencing for Lymphomas: Perfecting a Pipeline for Personalized Pathobiologic and Prognostic Predictions. J Mol Diagn. 2018 03; 20(2):163-165.
    View on PubMed
  16. Lo C, Alvarez E, Ohgami RS, Jeng M. Case Report: Clinical Variation in Children With Thrombopoietin Receptor (C-MPL) Mutations: Report of 2 Cases. J Pediatr Hematol Oncol. 2018 01; 40(1):67-70.
    View on PubMed
  17. Kunder C, Cascio MJ, Bakke A, Venkataraman G, O'Malley DP, Ohgami RS. Predominance of CD4+ T Cells in T-Cell/Histiocyte-Rich Large B-Cell Lymphoma and Identification of a Subset of Patients With Peripheral B-Cell Lymphopenia. Am J Clin Pathol. 2017 Jun 01; 147(6):596-603.
    View on PubMed
  18. Hoffmann J, Ohgami RS. Hematolymphoid lesions of the breast. Semin Diagn Pathol. 2017 Sep; 34(5):462-469.
    View on PubMed
  19. Chung A, Hou Y, Ohgami RS, Von Gehr A, Fisk DG, Roskin KM, Li X, Gojenola L, Bangs CD, Arber DA, Fire AZ, Cherry AM, Zehnder JL, Gotlib J, Merker JD. A novel TRIP11-FLT3 fusion in a patient with a myeloid/lymphoid neoplasm with eosinophilia. Cancer Genet. 2017 Oct; 216-217:10-15.
    View on PubMed
  20. Koo M, Ohgami RS. Pediatric-type Follicular Lymphoma and Pediatric Nodal Marginal Zone Lymphoma: Recent Clinical, Morphologic, Immunophenotypic, and Genetic Insights. Adv Anat Pathol. 2017 May; 24(3):128-135.
    View on PubMed

Go to UCSF Profiles, powered by CTSI